Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

34 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Cefepime-Taniborbactam in Complicated Urinary Tract Infection.
Wagenlehner FM, Gasink LB, McGovern PC, Moeck G, McLeroth P, Dorr M, Dane A, Henkel T; CERTAIN-1 Study Team. Wagenlehner FM, et al. Among authors: mcgovern pc. N Engl J Med. 2024 Feb 15;390(7):611-622. doi: 10.1056/NEJMoa2304748. N Engl J Med. 2024. PMID: 38354140 Clinical Trial.
Omadacycline Pharmacokinetics: Influence of Mortality Risk Score among Patients with Community-Acquired Bacterial Pneumonia.
Trang M, Hammel JP, Lakota EA, Safir MC, Bhavnani SM, Friedrich L, Steenbergen JN, McGovern PC, Tzanis E, Rubino CM. Trang M, et al. Among authors: mcgovern pc. Antimicrob Agents Chemother. 2023 Jan 24;67(1):e0220121. doi: 10.1128/aac.02201-21. Epub 2022 Dec 19. Antimicrob Agents Chemother. 2023. PMID: 36533934 Free PMC article. No abstract available.
Evaluation of the Impact of Comorbidities on Omadacycline Pharmacokinetics.
Trang M, Lakota EA, Safir MC, Bhavnani SM, Friedrich L, Steenbergen JN, McGovern PC, Tzanis E, Rubino CM. Trang M, et al. Among authors: mcgovern pc. Antimicrob Agents Chemother. 2023 Apr 18;67(4):e0239721. doi: 10.1128/aac.02397-21. Epub 2023 Mar 14. Antimicrob Agents Chemother. 2023. PMID: 36916956 Free PMC article.
Clinical Efficacy of Patients With Secondary Bacteremia Treated With Omadacycline: Results From Phase 3 Acute Bacterial Skin and Skin Structure Infections and Community-Acquired Bacterial Pneumonia Studies.
Sakoulas G, Eckburg PB, Amodio-Groton M, Manley A, Tzanis E, Das AF, Noble R, McGovern PC. Sakoulas G, et al. Among authors: mcgovern pc. Open Forum Infect Dis. 2021 Jun 18;8(6):ofab136. doi: 10.1093/ofid/ofab136. eCollection 2021 Jun. Open Forum Infect Dis. 2021. PMID: 34160473 Free PMC article.
Omadacycline vs moxifloxacin in adults with community-acquired bacterial pneumonia.
Torres A, Garrity-Ryan L, Kirsch C, Steenbergen JN, Eckburg PB, Das AF, Curran M, Manley A, Tzanis E, McGovern PC. Torres A, et al. Among authors: mcgovern pc. Int J Infect Dis. 2021 Mar;104:501-509. doi: 10.1016/j.ijid.2021.01.032. Epub 2021 Jan 20. Int J Infect Dis. 2021. PMID: 33484864 Free article. Clinical Trial.
Safety and efficacy of omadacycline for treatment of community-acquired bacterial pneumonia and acute bacterial skin and skin structure infections in patients with mild-to-moderate renal impairment.
Cornely OA, File TM Jr, Garrity-Ryan L, Chitra S, Noble R, McGovern PC. Cornely OA, et al. Among authors: mcgovern pc. Int J Antimicrob Agents. 2021 Feb;57(2):106263. doi: 10.1016/j.ijantimicag.2020.106263. Epub 2020 Dec 14. Int J Antimicrob Agents. 2021. PMID: 33326848 Free article.
34 results